-+ 0.00%
-+ 0.00%
-+ 0.00%

Wells Fargo Maintains Overweight on Xenon Pharmaceuticals, Raises Price Target to $48

Benzinga·12/11/2025 17:12:31
語音播報
Wells Fargo analyst Benjamin Burnett maintains Xenon Pharmaceuticals (NASDAQ:XENE) with a Overweight and raises the price target from $44 to $48.